Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 9450776)

Published in Ann Neurol on January 01, 1998

Authors

G P Comi1, A Bordoni, S Salani, L Franceschina, M Sciacco, A Prelle, F Fortunato, M Zeviani, L Napoli, N Bresolin, M Moggio, C D Ausenda, J W Taanman, G Scarlato

Author Affiliations

1: Centro Dino Ferrari, Universita' degli Studi di Milano, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.

Articles citing this

A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet (2005) 16.79

Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet (2010) 1.70

Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am J Hum Genet (2010) 1.70

Mitochondrial defects in acute multiple sclerosis lesions. Brain (2008) 1.69

Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet (2000) 1.68

Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry (2005) 1.55

Cytochrome c oxidase dysfunction in oxidative stress. Free Radic Biol Med (2012) 1.52

A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV. Am J Hum Genet (1999) 1.36

Tissue-specific cytochrome c oxidase assembly defects due to mutations in SCO2 and SURF1. Biochem J (2005) 1.23

Biology of mitochondria in neurodegenerative diseases. Prog Mol Biol Transl Sci (2012) 1.22

Analysis of mouse models of cytochrome c oxidase deficiency owing to mutations in Sco2. Hum Mol Genet (2010) 1.21

A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy. Am J Hum Genet (1999) 1.20

Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases. Pharmaceuticals (Basel) (2010) 1.13

Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene. Am J Hum Genet (2000) 1.11

Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol (2000) 1.10

The role of mitochondria in neurodegenerative diseases. J Neurol (2011) 1.05

The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy. Biochim Biophys Acta (2009) 0.98

De novo mtDNA point mutations are common and have a low recurrence risk. J Med Genet (2016) 0.97

Isolated cytochrome c oxidase deficiency in G93A SOD1 mice overexpressing CCS protein. J Biol Chem (2008) 0.94

Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis. Biochim Biophys Acta (2014) 0.92

Mitochondrial DNA sequence variation and neurodegeneration. Hum Genomics (2008) 0.91

Targeting angiogenin in therapy of amyotropic lateral sclerosis. Expert Opin Ther Targets (2008) 0.89

Motor neurone disease. BMJ (1999) 0.88

Mitochondrial genome changes and neurodegenerative diseases. Biochim Biophys Acta (2013) 0.87

Mitochondrial pathobiology in ALS. J Bioenerg Biomembr (2011) 0.86

Introducing a novel human mtDNA mutation into the Paracoccus denitrificans COX I gene explains functional deficits in a patient. Neurogenetics (2005) 0.86

hCOA3 stabilizes cytochrome c oxidase 1 (COX1) and promotes cytochrome c oxidase assembly in human mitochondria. J Biol Chem (2013) 0.85

Mitochondrial cytochrome c oxidase deficiency. Clin Sci (Lond) (2016) 0.84

The mitochondrial genome sequence of Mus terricolor: comparison with Mus musculus domesticus and implications for xenomitochondrial mouse modeling. Gene (2008) 0.82

Specific electron transport chain abnormalities in amyotrophic lateral sclerosis. J Neurol (2009) 0.82

Disorders related to mitochondrial membranes: pathology of the respiratory chain and neurodegeneration. J Inherit Metab Dis (2000) 0.82

Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol (2016) 0.82

Structural analysis of mitochondrial mutations reveals a role for bigenomic protein interactions in human disease. PLoS One (2013) 0.81

Respiratory chain deficiency in aged spinal motor neurons. Neurobiol Aging (2014) 0.79

SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis. Front Cell Neurosci (2015) 0.77

A(a)LS: Ammonia-induced amyotrophic lateral sclerosis. F1000Res (2015) 0.75

Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study. Acta Neuropathol Commun (2014) 0.75

Inhibiting Cytochrome C Oxidase Leads to Alleviated Ischemia Reperfusion Injury. Korean Circ J (2017) 0.75

Frequency of mitochondrial transfer RNA mutations and deletions in 225 patients presenting with respiratory chain deficiencies. J Med Genet (2001) 0.75

Mitochondrial DNA variations in Madras motor neuron disease. Mitochondrion (2013) 0.75

Investigation of the mitochondrial genome in patients with atypical motor neuron disease. J Neurol (2007) 0.75

Articles by these authors

Identification and characterization of a spinal muscular atrophy-determining gene. Cell (1995) 17.41

Multi-system neurological disease is common in patients with OPA1 mutations. Brain (2010) 5.37

Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science (1999) 5.20

Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet (2001) 5.09

Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med (1989) 4.87

Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell (1998) 4.41

Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am J Hum Genet (1998) 3.86

Mitochondrial myopathies. Ann Neurol (1985) 3.81

Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet (1997) 3.48

Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet (1998) 3.08

A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science (1989) 3.02

De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science (1994) 2.87

Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science (1993) 2.75

In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol (1991) 2.70

Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science (2000) 2.66

Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta (2004) 2.52

Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33

Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol (1987) 2.20

Identification of the gene encoding the human mitochondrial RNA polymerase (h-mtRPOL) by cyberscreening of the Expressed Sequence Tags database. Hum Mol Genet (1997) 2.15

Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol (2001) 2.06

Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med (1991) 2.05

High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology (1993) 2.02

Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy. Neurology (1999) 2.01

Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology (2005) 2.01

Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death Dis (2012) 1.89

Evidence that nebulin is a protein-ruler in muscle thin filaments. FEBS Lett (1991) 1.87

Epidemiology of hematological malignancies. Ann Oncol (2007) 1.87

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86

Limb immobilization for the treatment of focal occupational dystonia. Neurology (2001) 1.85

Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology (1986) 1.78

Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis (2008) 1.77

Assembly of cytochrome-c oxidase in cultured human cells. Eur J Biochem (1998) 1.70

Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer (2008) 1.70

Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant. Br J Cancer (2009) 1.68

Characterization of SURF-1 expression and Surf-1p function in normal and disease conditions. Hum Mol Genet (1999) 1.66

Abdominal volume contribution to tidal volume as an early indicator of respiratory impairment in Duchenne muscular dystrophy. Eur Respir J (2009) 1.65

Remarkable infidelity of polymerase gammaA associated with mutations in POLG1 exonuclease domain. Neurology (2003) 1.65

Dementia is a major predictor of death among the Italian elderly. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology (1999) 1.64

Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol (2008) 1.64

Loss-of-function mutations of SURF-1 are specifically associated with Leigh syndrome with cytochrome c oxidase deficiency. Ann Neurol (1999) 1.63

Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol (1999) 1.63

A mutation in the human heme A:farnesyltransferase gene (COX10 ) causes cytochrome c oxidase deficiency. Hum Mol Genet (2000) 1.62

Mammalian cytochrome-c oxidase: characterization of enzyme and immunological detection of subunits in tissue extracts and whole cells. Methods Enzymol (1995) 1.59

Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients. J Peripher Nerv Syst (1997) 1.57

Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56

A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes (1999) 1.56

A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet (2001) 1.55

Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum Mol Genet (1995) 1.54

Diagnostic value of succinate ubiquinone reductase activity in the identification of patients with mitochondrial DNA depletion. J Inherit Metab Dis (2002) 1.51

Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells. Mitochondrion (2012) 1.49

Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia (1998) 1.45

Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology (2003) 1.43

Postcontraction depression of reciprocal inhibition in human forearm muscles. Muscle Nerve (2000) 1.43

A CAV3 microdeletion differentially affects skeletal muscle and myocardium. Neurology (2003) 1.41

Single-stranded-DNA-binding proteins from human mitochondria and Escherichia coli have analogous physicochemical properties. Eur J Biochem (1994) 1.41

A tentative interpretation of electromyographic regional differences in bulbar- and limb-onset ALS. Neurology (1999) 1.39

Immunocytochemistry of muscle cytoskeletal proteins in acid maltase deficiency. Muscle Nerve (1994) 1.39

GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology (2006) 1.39

Identification and characterization of human cDNAs specific to BCS1, PET112, SCO1, COX15, and COX11, five genes involved in the formation and function of the mitochondrial respiratory chain. Genomics (1998) 1.38

Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord (1993) 1.38

Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am J Hum Genet (1990) 1.36

Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology (2006) 1.36

An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet (1995) 1.36

MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology (1988) 1.34

Sulfatides trigger increase of cytosolic free calcium and enhanced expression of tumor necrosis factor-alpha and interleukin-8 mRNA in human neutrophils. Evidence for a role of L-selectin as a signaling molecule. J Biol Chem (1994) 1.33

Type I tyrosinemia: lack of immunologically detectable fumarylacetoacetase enzyme protein in tissues and cell extracts. Pediatr Res (1987) 1.33

A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology (2004) 1.33

Subunit Va of human and bovine cytochrome c oxidase is highly conserved. Gene (1988) 1.33

Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat (2008) 1.33

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann Neurol (1998) 1.32

Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J Neurol Sci (2001) 1.31

Rapid detection of the A----G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF). Am J Hum Genet (1991) 1.31

Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc (2000) 1.30

Expression of mtDNA and nDNA encoded respiratory chain proteins in chemically and genetically-derived Rho0 human fibroblasts: a comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome. Biochim Biophys Acta (1997) 1.29

Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies. Ann Neurol (1990) 1.28

Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Hum Mol Genet (1997) 1.28

Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann Neurol (1989) 1.28

Stem cell therapy in stroke. Cell Mol Life Sci (2009) 1.27

Motoneuron-disease-like disorder after ganglioside therapy. Lancet (1991) 1.26

Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp (2007) 1.25

Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci (1999) 1.25

Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. J Neuroimmunol (1999) 1.25

Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med (1988) 1.25

Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle. Neurology (1985) 1.25